The National Institute for Health and Care Excellence (NICE) has recommended that a weekly injection of semaglutide is given to more than a million people to help prevent heart attacks and strokes. This latest recommendation is underpinned by several years of research supported by the NIHR. 

Del Bains aged 57 from Leicester was finding it harder and harder to manage his type 2 diabetes, until a conversation led him to the COMBINE study at the Leicester Diabetes Centre.

The upcoming 2026 Obesity & Weight Management Alliance UK conference series will bring together leading clinicians, researchers and policymakers to explore innovative, evidence‑based approaches to tackling obesity.